Prof Eugene Athan

Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial

J Green, A McGuinness, M Berk, D Castle, E Athan, C Hair, P Strandwitz, A Loughman, A Nierenberg, J Cryan, M Mohebbi, F Jacka

(2023), Vol. 9, Pilot and Feasibility Studies, C1

Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial

J Green, M Berk, M Mohebbi, A Loughman, A McGuinness, D Castle, M Chatterton, J Perez, P Strandwitz, E Athan, C Hair, A Nierenberg, J Cryan, F Jacka

(2023), Canadian Journal of Psychiatry, C1

Pediatric Staphylococcus aureus Bacteremia: Clinical Spectrum and Predictors of Poor Outcome

A Campbell, L Al Yazidi, L Phuong, C Leung, E Best, R Webb, L Voss, E Athan, P Britton, P Bryant, C Butters, J Carapetis, N Ching, G Coombs, D Daley, J Francis, T Hung, S Mowlaboccus, C Nourse, S Ojaimi, A Tai, N Vasilunas, B McMullan, C Blyth, A Bowen

(2022), Vol. 74, pp. 604-613, Clinical Infectious Diseases, Oxford, Eng., C1

Predictors of treatment success following peri-prosthetic joint infection: 24-month follow up from a multi-center prospective observational cohort study of 653 patients

Joshua Davis, Sarah Metcalf, Benjamin Clark, J Robinson, Paul Huggan, Chris Luey, Stephen McBride, Craig Aboltins, Renjy Nelson, David Campbell, L Solomon, Kellie Schneider, Mark Loewenthal, Piers Yates, Eugene Athan, Darcie Cooper, Babak Rad, Tony Allworth, Alistair Reid, Kerry Read, Peter Leung, Archana Sud, Vana Nagendra, Roy Chean, Chris Lemoh, Nora Mutalima, Ton Tran, Kate Grimwade, Marjoree Sehu, Davis Looke, Adrienne Torda, Thi Aung, Steven Graves, David Paterson, Laurens Manning

(2022), Vol. 9, pp. 1-9, Open Forum Infectious Diseases, Oxford, Eng., C1

Area-level social and economic factors and the local incidence of SARS-CoV-2 infections in Victoria during 2020

C Roder, C Maggs, B McNamara, D O'Brien, A Wade, C Bennett, J Pasco, E Athan

(2022), Vol. 216, pp. 349-356, Medical Journal of Australia, London, Eng., C1

Whole genome sequencing and molecular epidemiology of paediatric Staphylococcus aureus bacteraemia

A Campbell, S Mowlaboccus, G Coombs, D Daley, L Al Yazidi, L Phuong, C Leung, E Best, R Webb, L Voss, E Athan, P Britton, P Bryant, C Butters, J Carapetis, N Ching, J Francis, T Hung, C Nourse, S Ojaimi, A Tai, N Vasilunas, B McMullan, A Bowen, C Blyth

(2022), Vol. 29, pp. 197-206, Journal of Global Antimicrobial Resistance, Amsterdam, The Netherlands, C1

Early SARS-CoV-2-associated acute transverse myelitis: A case for neurotropism?

I Lu, J Cornish, A Ashok, S Chen, E Athan, A Hughes

(2022), Vol. 292, pp. 679-683, Journal of Internal Medicine, London, Eng., C1

Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial

R Mallory, N Formica, S Pfeiffer, B Wilkinson, A Marcheschi, G Albert, H McFall, M Robinson, J Plested, M Zhu, S Cloney-Clark, B Zhou, G Chau, A Robertson, S Maciejewski, H Hammond, L Baracco, J Logue, M Frieman, G Smith, N Patel, G Glenn, M Adams, M Arya, E Athan, I Berger, P Bradley, T Briskin, R Glover, P Griffin, J Kim, S Kitchener, T Klein, A Leah, I Leelasena, C Lemech, J Lickliter, M Manning, F Napier-Flood, P Nugent, S Thackwray, M Turner

(2022), Vol. 22, pp. 1565-1576, The Lancet Infectious Diseases, United States, C1-1

Environmental risk factors associated with the presence of Mycobacterium ulcerans in Victoria, Australia

K Blasdell, B McNamara, D O’Brien, M Tachedjian, V Boyd, M Dunn, P Mee, S Clayton, J Gaburro, I Smith, K Gibney, E Tay, E Hobbs, N Waidyatillake, S Lynch, T Stinear, E Athan

(2022), Vol. 17, pp. e0274627-e0274627, PLoS ONE, United States, C1

Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection

A McAuley, P Jansen van Vuren, M Mohammed, Faheem, S Goldie, S Riddell, N Gödde, I Styles, M Bruce, S Chahal, S Keating, K Blasdell, M Tachedjian, C O’Brien, N Singanallur, J Viana, A Vashi, C Kirkpatrick, C MacRaild, R Shah, E Vincan, E Athan, D Creek, N Trevaskis, S Murugesan, A Kumar, S Vasan

(2022), Vol. 14, pp. 1-18, Viruses, Basel, Switzerland, C1

Aerococcus urinae, a rare cause of aortic root abscess: a case report

C Tiong, C Bartolo, A Walton, E Athan

(2022), Vol. 16, Journal of Medical Case Reports, C1

The Economic Burden of Infective Endocarditis due to Injection Drug Use in Australia: A Single Centre Study - University Hospital Geelong, Barwon Health, Victoria

O Otome, A Wright, V Gunjaca, S Bowe, E Athan

(2022), Vol. 2022, pp. 1-5, Interdisciplinary Perspectives on Infectious Diseases, Egypt, C1

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

A Strezova, J Diez-Domingo, K Al Shawafi, J Tinoco, M Shi, P Pirrotta, A Mwakingwe-Omari, M Adams, A Ahonen, C Andrews, E Athan, J Barbagómez, P Barbanti, E Barberan, A Baty, N Bengtsson, J Berger-Roscher, K Blom, J Beytout, L Boucher, C Boutry, A Boye, F Brault, L Breger, C Cuixart, C Caso, C Cerna, H Cheng, H Cheong, E Choo, C Cunha, A Cunningham, D Curiac, B Daguzan, A Dahmen, S Datta, M Desole, E Paolo, M Dionne, P Dite, J Dutz, J Earl, T Eckermann, W Ellison, J Eremenko, M Esen, T Eto, X Fabré, C Farrington, M Ferguson, P Ferrand, M Finneran, D Francyk, M Freedman, G Freeman, A Freire, P Gal, J Gauthier, B Gerlach, W Ghesquiere, I Gorfinkel, C Grigat, J Grosskopf, M Hamann, P Hanrion, P Hartley, A Hastie, K Heaton, A Himpel-Boenninghoff, T Horacek, D Hui, Y Huong, S Hwang, G Icardi, G Illies, J Irimajiri, W Jacob, A Jambrecina, T Avelino-Silva, G Kalema, H Kim, C Klein, U Kleinecke, H Koenig, S Kokko, P Kosina, S Koski, P Koskinen, M Kropp, R Kuroki, O Laajalahti, P Lachance, J Lee, J Lee, P Levins, R Lipetz, B Liu, C Liu, M Lundvall, L Magimaiseelan

(2022), Vol. 9, pp. ofac485-, Open Forum Infectious Diseases, United States, C1

Association between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated with Piperacillin/Tazobactam or Meropenem from the MERINO Study

A Henderson, D Paterson, M Chatfield, P Tambyah, D Lye, P De, R Lin, K Chew, M Yin, T Lee, M Yilmaz, R Cakmak, T Alenazi, Y Arabi, M Falcone, M Bassetti, E Righi, B Rogers, S Kanj, H Bhally, J Iredell, M Mendelson, T Boyles, D Looke, N Runnegar, S Miyakis, G Walls, M Khamis, A Zikri, A Crowe, P Ingram, N Daneman, P Griffin, E Athan, L Roberts, S Beatson, A Peleg, K Cottrell, M Bauer, E Tan, K Chaw, G Nimmo, T Harris-Brown, P Harris

(2021), Vol. 73, pp. E3842-E3850, Clinical Infectious Diseases, United States, C1

Preventing the development of severe COVID-19 by modifying immunothrombosis

G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk

(2021), Vol. 264, Life Sciences, Netherlands, C1

Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs

J Pericàs, J Llopis, E Athan, M Hernández-Meneses, M Hannan, D Murdoch, Z Kanafani, T Freiberger, J Strahilevitz, N Fernández-Hidalgo, C Lamas, E Durante-Mangoni, P Tattevin, F Nacinovich, V Chu, J Miró

(2021), Vol. 77, pp. 544-555, Journal of the American College of Cardiology, United States, C1

Infective endocarditis in patients on chronic hemodialysis

J Pericàs, J Llopis, M Jiménez-Exposito, W Kourany, B Almirante, G Carosi, E Durante-Mangoni, C Fortes, E Giannitsioti, S Lerakis, R Montagna-Mella, J Ambrosioni, R Tan, C Mestres, D Wray, O Pachirat, A Moreno, V Chu, E de Lazzari, V Fowler, J Miró, L Clara, M Sanchez, J Casabé, C Cortes, F Nacinovich, P Oses, R Ronderos, A Sucari, J Thierer, J Altclas, S Kogan, D Spelman, E Athan, O Harris, K Kennedy, R Tan, D Gordon, L Papanicolas, T Korman, D Kotsanas, R Dever, P Jones, P Konecny, R Lawrence, D Rees, S Ryan, M Feneley, J Harkness, J Post, P Reinbott, R Gattringer, F Wiesbauer, A Andrade, A Passos de Brito, A Guimarães, M Grinberg, A Mansur, R Siciliano, T Varejao Strabelli, M Campos Vieira, R de Medeiros Tranchesi, M Paiva, A de Oliveira Ramos, C Weksler, G Ferraiuoli, W Golebiovski, C Lamas, J Karlowsky, Y Keynan, A Morris, E Rubinstein, S Jones, P Garcia, M Cereceda, A Fica, R Mella, R Fernandez, L Franco, J Gonzalez, A Jaramillo, B Barsic, S Bukovski, V Krajinovic, A Pangercic, I Rudez, J Vincelj, T Freiberger, J Pol, B Zaloudikova, Z Ashour, A El Kholy, M Mishaal, D Osama, H Rizk, N Aissa, C Alauzet, F Alla, C Campagnac, T Doco-Lecompte

(2021), Vol. 77, pp. 1629-1640, Journal of the American College of Cardiology, Amsterdam, The Netherlands, C1

C-reactive protein predicts complications in community-associated S. aureus bacteraemia: a cohort study

C Botheras, S Bowe, R Cowan, E Athan

(2021), Vol. 21, BMC Infectious Diseases, England, C1

The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?

G Morris, C Bortolasci, B Puri, W Marx, A O'Neil, E Athan, K Walder, M Berk, L Olive, A Carvalho, M Maes

(2021), Vol. 144, Cytokine, England, C1

The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study

F Chiong, M Wasef, K Liew, R Cowan, D Tsai, Y Lee, L Croft, O Harris, S Gwini, E Athan

(2021), Vol. 21, BMC Infectious Diseases, England, C1

Barriers to performing onsite COVID-19 testing during the second wave in Victoria

M Haque, A Ferdous, J Miller, C Dixon, E Athan, N Friedman

(2021), Vol. 50, pp. 845-849, Australian Journal of General Practice, Australia, C1

Enterococcal bacteraemia 'silent but deadly': a population-based cohort study

I Cabiltes, S Coghill, S Bowe, E Athan

(2020), Vol. 50, pp. 434-440, Internal Medicine Journal, Australia, C1

Six vs eight weeks of antibiotics for small Mycobacterium ulcerans lesions in Australian patients

Daniel O’brien, N Friedman, Raquel Cowan, Aaron Walton, Eugene Athan

(2020), Vol. 70, pp. 1993-1997, Clinical infectious diseases, Oxford, Eng., C1

Antimicrobial anaphylaxis: The changing face of severe antimicrobial allergy

V Hall, M Wong, M Munsif, B Stevenson, K Elliott, M Lucas, A Baird, E Athan, M Young, R Pickles, A Cheng, A Stewardson, A Aung, J Trubiano

(2020), Vol. 75, pp. 229-235, Journal of Antimicrobial Chemotherapy, England, C1

Cost and Outcomes of Implantable Cardiac Electronic Device Infections in Victoria, Australia

C Roder, V Gunjaca, O Otome, S Gwini, E Athan

(2020), Vol. 29, pp. E140-E146, Heart Lung and Circulation, Amsterdam, The Netherlands, C1

International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass

B Hasse, M Hannan, P Keller, F Maurer, R Sommerstein, D Mertz, D Wagner, N Fernández-Hidalgo, J Nomura, V Manfrin, D Bettex, A Hernandez Conte, E Durante-Mangoni, T Tang, R Stuart, J Lundgren, S Gordon, M Jarashow, P Schreiber, S Niemann, T Kohl, C Daley, A Stewardson, C Whitener, K Perkins, D Plachouras, T Lamagni, M Chand, T Freiberger, S Zweifel, P Sander, B Schulthess, J Scriven, H Sax, J van Ingen, C Mestres, D Diekema, B Brown-Elliott, R Wallace, L Baddour, J Miro, B Hoen, E Athan, A Bayer, B Barsic, G Corey, V Chu, D Durack, C Fortes, V Fowler, A Krachmer, W Wilson, R Stewart, L Herwaldt, A Widmer, B Brown Elliot, V Falk, M Halbe

(2020), Vol. 104, pp. 214-235, Journal of Hospital Infection, England, C1

Necrotising enterocolitis caused by Clostridium perfringens: a life-threatening manifestation of a common foodborne infection

H Walker, K Liew, V Adams, S Larcombe, S Nagra, G Guest, E Athan

(2020), Vol. 213, pp. 114-115.e1, Medical Journal of Australia, Australia, C1

Cell-mediated and serology-based tests for Mycobacterium ulcerans disease: A systematic review and meta-analysis

M Avumegah, N Waidyatillake, W Michalski, D O’brien, T Nelson, E Athan

(2020), Vol. 14, pp. 1-15, PLoS Neglected Tropical Diseases, United States, C1

In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection

C Roder, E Athan

(2020), Vol. 20, pp. 209-216, Drugs in R and D, New Zealand, C1

Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients

L Manning, S Metcalf, B Clark, J Robinson, P Huggan, C Luey, S McBride, C Aboltins, R Nelson, D Campbell, L Solomon, K Schneider, M Loewenthal, P Yates, E Athan, D Cooper, B Rad, T Allworth, A Reid, K Read, P Leung, A Sud, V Nagendra, R Chean, C Lemoh, N Mutalima, K Grimwade, M Sehu, A Torda, T Aung, S Graves, D Paterson, J Davis

(2020), Vol. 7, Open Forum Infectious Diseases, United States, C1

Risk factors associated with antibiotic treatment failure of Buruli ulcer

D O’Brien, N Deborah Friedman, A Walton, A Hughes, E Athan

(2020), Vol. 64, Antimicrobial agents and chemotherapy, United States, C1

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach

G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk

(2020), Vol. 258, Life Sciences, Netherlands, C1

The effectiveness of a simple antimicrobial stewardship intervention in general practice in Australia: A pilot study

A Neels, A Bloch, S Gwini, E Athan

(2020), Vol. 20, BMC Infectious Diseases, England, C1

Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

G Morris, E Athan, K Walder, C Bortolasci, A O'Neil, W Marx, M Berk, A Carvalho, M Maes, B Puri

(2020), Vol. 262, Life Sciences, Netherlands, C1

Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis

J Green, J Davis, M Berk, C Hair, A Loughman, D Castle, E Athan, A Nierenberg, J Cryan, F Jacka, W Marx

(2020), Vol. 12, pp. 1-25, Gut Microbes, United States, C1

Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older

D Curran, L Oostvogels, T Heineman, S Matthews, J McElhaney, S McNeil, J Diez-Domingo, H Lal, C Andrews, E Athan, J Berglund, L Campora, F De Looze, T Korhonen, E Leung, M Levin, A Volpi, R Johnson

(2019), Vol. 74, pp. 1231-1238, Journals of Gerontology - Series A Biological Sciences and Medical Sciences, United States, C1

The changing epidemiology worldwide of Mycobacterium ulcerans

D O'Brien, I Jeanne, K Blasdell, M Avumegah, E Athan

(2019), Vol. 147, pp. 1-8, Epidemiology and infection, Cambridge, Eng., C1

Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality

D O'Brien, P Callan, N Friedman, E Athan, A Hughes, A McDonald

(2019), Vol. 89, pp. 653-658, ANZ journal of surgery, Chichester, Eng., C1

Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units

M Jardine, R Commons, J de Zoysa, M Wong, N Gilroy, J Green, B Henderson, R Stuart, D Tunnicliffe, C van Eps, E Athan

(2019), Vol. 24, pp. 951-957, Nephrology, Australia, C1

Australian infection control in endoscopy consensus statements on carbapenemase-producing Enterobacteriaceae

Benedict Devereaux, Eugene Athan, Robyn Brown, Sue Greig, Dianne Jones, Fiona Bailey, David Wallis, Rajvinder Singh

(2019), Vol. 34, pp. 650-658, Journal of gastroenterology and hepatology, London, Eng., C1

Association between the timing of surgery for complicated, left-sided infective endocarditis and survival

A Wang, V Chu, E Athan, F Delahaye, T Freiberger, C Lamas, J Miro, J Strahilevitz, C Tribouilloy, E Durante-Mangoni, J Pericas, N Fernández-Hidalgo, F Nacinovich, B Barsic, E Giannitsioti, J Hurley, M Hannan, L Park

(2019), Vol. 210, pp. 108-116, American Heart Journal, United States, C1

The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis

E Fosbøl, L Park, V Chu, E Athan, F Delahaye, T Freiberger, C Lamas, J Miro, J Strahilevitz, C Tribouilloy, E Durante-Mangoni, J Pericas, N Fernández-Hidalgo, F Nacinovich, H Rizk, B Barsic, E Giannitsioti, J Hurley, M Hannan, A Wang

(2019), Vol. 40, pp. 2243-2251, European Heart Journal, England, C1

Spontaneous healing of mycobacterium ulcerans disease in australian patients

D O’Brien, A Murrie, P Meggyesy, J Priestley, A Rajcoomar, E Athan

(2019), Vol. 13, PLoS Neglected Tropical Diseases, United States, C1

Simethicone use during gastrointestinal endoscopy: position statement of the Gastroenterological Society of Australia

B Devereaux, A Taylor, E Athan, D Wallis, R Brown, S Greig, F Bailey, K Vickery, E Wardle, D Jones

(2019), Vol. 34, pp. 2086-2089, Journal of gastroenterology and hepatology, Chichester, Eng., C1

Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: Epidemiology, microbiology and outcomes

Z Aminzadeh, P Simpson, E Athan

(2019), Vol. 24, pp. 222-228, Infection, Disease and Health, Amsterdam, The Netherlands, C1

An emerging human parechovirus type 5 causing sepsis-like illness in infants in Australia

A Chamings, K Liew, E Reid, E Athan,, A Raditsis, P Vuillermin, Y Yoga, L Caly, J Druce, S Alexandersen

(2019), Vol. 11, Viruses, Switzerland, C1

Critical care burden of skin and soft tissue infection in Central Australia: More than skin deep

P Secombe, Y Planche, E Athan, J Ollapallil

(2019), Vol. 27, pp. 550-556, Australian Journal of Rural Health, London, Eng., C1

The Current Epidemiology of Injecting Drug Use-Associated Infective Endocarditis in Victoria, Australia in the Midst of Increasing Crystal Methamphetamine Use

A Wright, O Otome, C Harvey, S Bowe, E Athan

(2018), Vol. 27, pp. 484-488, Heart Lung and Circulation, Australia, C1

Severe Rhabdomyolysis Associated with RSV

J Bender, R Chew, B Lin, E Athan

(2018), Vol. 5, Open Forum Infectious Diseases, United States, C1

Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

N Holmes, J Robinson, S van Hal, W Munckhof, E Athan, T Korman, A Cheng, J Turnidge, P Johnson, B Howden, J Owen Robinson

(2018), Vol. 18, BMC Infectious Diseases, England, C1

Managing diabetic foot infections: A survey of Australasian infectious diseases clinicians

R Commons, E Raby, E Athan, H Bhally, S Chen, S Guy, P Ingram, K Lai, C Lemoh, L Lim, L Manning, S Miyakis, M O'Reilly, A Roberts, M Sehu, A Torda, M Vicaretti, P Lazzarini

(2018), Vol. 11, Journal of Foot and Ankle Research, England, C1

Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C

A Wade, A McCormack, C Roder, K McDonald, M Davies, N Scott, M Wardrop, E Athan, M Hellard

(2018), Vol. 25, pp. 1089-1098, Journal of Viral Hepatitis, England, C1

Scrub typhus diagnosis on acute specimens using serological and molecular assays - a 3-year prospective study

M Koralur, R Singh, M Varma, S Shenoy, V Acharya, A Kamath, J Stenos, E Athan, I Bairy

(2018), Vol. 91, pp. 112-117, Diagnostic microbiology and infectious disease, Amsterdam, The Netherlands, C1

Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease

D O’Brien, N Friedman, A McDonald, P Callan, A Hughes, A Walton, E Athan

(2018), Vol. 12, PLoS Neglected Tropical Diseases, United States, C1

Increased severity and spread of Mycobacterium ulcerans, Southeastern Australia

Alex Tai, Eugene Athan, N Friedman, Andrew Hughes, Aaron Walton, Daniel O'Brien

(2018), Vol. 24, pp. 58-64, Emerging infectious diseases, Atlanta, Ga., C1

Bilateral osteomyelitis and liver abscess caused by hypervirulent Klebsiella pneumoniae- a rare clinical manifestation (case report)

E Sturm, A Tai, B Lin, J Kwong, E Athan, B Howden, R Angliss, R Asaid, J Pollard

(2018), Vol. 18, BMC Infectious Diseases, England, C1

Low incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic region

J Wynne, T Stinear, E Athan, W Michalski, D O’Brien

(2018), Vol. 12, PLoS Neglected Tropical Diseases, United States, C1

Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance

P Harris, P Tambyah, D Lye, Y Mo, T Lee, M Yilmaz, T Alenazi, Y Arabi, M Falcone, M Bassetti, E Righi, B Rogers, S Kanj, H Bhally, J Iredell, M Mendelson, T Boyles, D Looke, S Miyakis, G Walls, M Al Khamis, A Zikri, A Crowe, P Ingram, N Daneman, P Griffin, E Athan, P Lorenc, P Baker, L Roberts, S Beatson, A Peleg, T Harris-Brown, D Paterson, J McNamara, R Sieler, J Garlick, J Costa, J Roney, N Pratt, H Tabaja, J Kmeid, R Tayyar, S El Zein, S Jones, R Cowan, A Tai, B Lin, B Rad, E MacMorran, J Pollard, R Dinleyici, A Istanbullu, B Ceylan, A Mert, M Hashhoush, T Dalwi, T Korman, R Azzam, M Birrell, C Hughes, S Khan, J Lau, L Lee, K Lim, Y Lin, D Lister, D New, N Rafiei, J Stewart, M Trad, V Aye Yeung, S McBride, D Holland, C Hopkins, C Luey, S Taylor, S Morpeth, M Finney, M Martin, U Holland, J Ali, R Jureen, N Underwood, A Henderson, N Runnegar, M Slavin, O Robinson, A Rishu, S Shawkat, J Fish, K Chin Liew, P Newton, M Merelli, A Carnelutti, S Ussai, D Pecori, E Izharuddin, B Young

(2018), Vol. 320, pp. 984-994, JAMA - Journal of the American Medical Association, United States, C1

Health issues of refugees attending an infectious disease refugee health clinic in a regional Australian hospital

P Masters, P Lanfranco, E Sneath, A Wade, S Huffam, J Pollard, J Standish, K McCloskey, E Athan, D O'Brien, N Friedman

(2018), Vol. 47, pp. 305-310, Australian journal of general practice, Melbourne, Vic., C1

Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units

H Miller, A Tong, D Tunnicliffe, D Campbell, J Pinter, R Commons, E Athan, J Craig, N Gilroy, J Green, B Henderson, M Howell, R Stuart, C van Eps, M Wong, J de Zoysa, M Jardine

(2017), Vol. 21, pp. 213-223, Hemodialysis international, Hoboken, N.J., C1

Antimicrobial stewardship in general practice

A Neels, A Tai, F Devchand, E Athan

(2017), Vol. 18, pp. 55-58, Medicine today, Neutral Bay, N.S.W., C1

Exposure risk for infection and lack of human-to-human transmission of Mycobacterium ulcerans disease, Australia

D O’Brien, J Wynne, A Buultjens, W Michalski, T Stinear, N Friedman, A Hughes, E Athan

(2017), Vol. 23, pp. 837-840, Emerging Infectious Diseases, United States, C1

High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA

S Harch, E MacMorran, S Tong, D Holt, J Wilson, E Athan, S Hewagama

(2017), Vol. 17, BMC Infectious Diseases, England, C1

The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia

E Macmorran, S Harch, E Athan, S Lane, S Tong, L Crawford, S Krishnaswamy, S Hewagama

(2017), Vol. 145, pp. 2817-2826, Epidemiology and infection, Cambridge, Eng., C1

Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis

J Pericàs, J Messina, C Garcia-de-la-Mària, L Park, B Sharma-Kuinkel, F Marco, D Wray, Z Kanafani, M Carugati, E Durante-Mangoni, P Tattevin, V Chu, A Moreno, V Fowler, J Miró, International Collaboration on Endocarditis Microb, Eugene Athan

(2017), Vol. 23, pp. 544-549, Clinical Microbiology and Infection, Amsterdam, The Netherlands, C1-1

Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients

Daniel O'Brien, Deborah Friedman, Andrew Hughes, Aaron Walton, Eugene Athan

(2017), Vol. 47, pp. 1011-1019, Internal medicine journal, Chichester, Eng., C1

One Health approach to controlling a Q fever outbreak on an Australian goat farm

K Bond, G Vincent, C Wilks, L Franklin, B Sutton, J Stenos, R Cowan, K Lim, E Athan, O Harris, L Macfarlane-Berry, Y Segal, S Firestone

(2016), Vol. 144, pp. 1129-1141, Epidemiology and Infection, England, C1

Mucormycosis in Australia: contemporary epidemiology and outcomes

K Kennedy, K Daveson, M Slavin, S van Hal, T Sorrell, A Lee, D Marriott, B Chapman, C Halliday, K Hajkowicz, E Athan, N Bak, E Cheong, C Heath, C Morrissey, S Kidd, R Beresford, C Blyth, T Korman, J Robinson, W Meyer, S Chen

(2016), Vol. 22, pp. 775-781, Clinical microbiology and infection, Amsterdam, The Netherlands, C1

Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand

J Trubiano, A Cheng, T Korman, C Roder, A Campbell, M May, C Blyth, J Ferguson, T Blackmore, T Riley, E Athan

(2016), Vol. 46, pp. 479-493, Internal Medicine Journal, Australia, C1

Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older

A Cunningham, H Lal, M Kovac, R Chlibek, S Hwang, J Díez-Domingo, O Godeaux, M Levin, J McElhaney, J Puig-Barberà, C Vanden Abeele, T Vesikari, D Watanabe, T Zahaf, A Ahonen, E Athan, J Barba-Gomez, L Campora, F De Looze, H Downey, W Ghesquiere, I Gorfinkel, T Korhonen, E Leung, S McNeil, L Oostvogels, L Rombo, J Smetana, L Weckx, W Yeo, T Heineman

(2016), Vol. 375, pp. 1019-1032, New England Journal of Medicine, United States, C1

Infection control in a globalised world challenges for general practice

A Tai, J Heath, A Neels, E Athan

(2016), Vol. 17, pp. 37-45, Medicine Today, Australia, C1-1

Validated risk score for predicting 6-month mortality in infective endocarditis

Lawrence Park, Vivian Chu, Gail Peterson, Athanasios Skoutelis, Tatjana Lejko-Zupa, Emilio Bouza, Pierre Tattevin, Gilbert Habib, Ren Tan, Javier Gonzalez, Javier Altclas, Jameela Edathodu, Claudio Fortes, Rinaldo Siciliano, Orathai Pachirat, Souha Kanj, Andrew Wang, International Collaboration on Endocarditis (ICE), Eugene Athan

(2016), Vol. 5, pp. 1-13, Journal of the American Heart Association, Chichester, Eng., C1

Increasing experience with primary oral medical therapy for mycobacterium ulcerans disease in an Australian cohort

N Friedman, Eugene Athan, Aaron Walton, Daniel O'Brien

(2016), Vol. 60, pp. 2692-2695, Antimicrobial agents and chemotherapy, Washington, D.C., C1-1

Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.

V Chu, L Park, E Athan, F Delahaye, T Freiberger, C Lamas, J Miro, D Mudrick, J Strahilevitz, C Tribouilloy, E Durante-Mangoni, J Pericas, N Fernández-Hidalgo, F Nacinovich, H Rizk, V Krajinovic, E Giannitsioti, J Hurley, M Hannan, A Wang

(2015), Vol. 131, pp. 131-140, Circulation, United States, C1

Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality

M Slavin, S van Hal, T Sorrell, A Lee, D Marriott, K Daveson, K Kennedy, K Hajkowicz, C Halliday, E Athan, N Bak, E Cheong, C Heath, C Orla Morrissey, S Kidd, R Beresford, C Blyth, T Korman, J Owen Robinson, W Meyer, S Chen, Australia and New Zealand Mycoses Interest Group

(2015), Vol. 21, pp. 490.e1-490.e10, Clinical Microbiology and Infection, Amsterdam, The Netherlands, C1

Sequence type 131 fimH30 and fimH41 subclones amongst escherichia coli isolates in Australia and New Zealand

B Rogers, P Ingram, N Runnegar, M Pitman, J Freeman, E Athan, S Havers, H Sidjabat, E Gunning, M De Almeida, K Styles, D Paterson

(2015), Vol. 45, pp. 351-358, International journal of antimicrobial agents, Amsterdam, The Netherlands, C1

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

P Harris, A Peleg, J Iredell, P Ingram, S Miyakis, A Stewardson, B Rogers, E McBryde, J Roberts, J Lipman, E Athan, S Paul, P Baker, T Harris-Brown, D Paterson

(2015), Vol. 16, pp. 1-8, Trials, London, Eng., C1

Survey of infection control and antimicrobial stewardship practices in Australian residential aged-care facilities

R Stuart, C Marshall, E Orr, N Bennett, E Athan, D Friedman, M Reilly, Members of RACRIG (Residential Aged Care Research

(2015), Vol. 45, pp. 576-580, Internal medicine journal, London, Eng., C1

Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins

N Berlon, R Qi, B Sharma-Kuinkel, H Joo, L Park, D George, J Thaden, J Messina, S Maskarinec, M Mueller-Premru, E Athan, P Tattevin, J Pericas, C Woods, M Otto, V Fowler

(2015), Vol. 71, pp. 447-457, Journal of infection, Amsterdam, The Netherlands, C1

Evolving epidemiology of injecting drug use-associated infective endocarditis: a regional centre experience

M Tung, M Light, R Giri, S Lane, A Appelbe, C Harvey, E Athan

(2015), Vol. 34, pp. 412-417, Drug and alcohol review, North Melbourne, Vic., C1

Mycobacterium ulcerans treatment - can antibiotic duration be reduced in selected patients?

R Cowan, E Athan, N Friedman, A Hughes, A McDonald, P Callan, J Fyfe, D O Brien

(2015), Vol. 9, pp. 1-12, PLoS neglected tropical diseases, San Francisco, Calif., C1-1

Candida infective endocarditis: an observational cohort study with a focus on therapy

C Arnold, M Johnson, A Bayer, S Bradley, E Giannitsioti, J Miró, P Tornos, P Tattevin, J Strahilevitz, D Spelman, E Athan, F Nacinovich, C Fortes, C Lamas, B Barsic, N Fernández-Hidalgo, P Muñoz, V Chu

(2015), Vol. 59, pp. 2365-2373, Antimicrobial agents and chemotherapy, Washington, D.C., C1-1

Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study

C Chirouze, F Alla, V Fowler, D Sexton, G Corey, V Chu, A Wang, M-L Erpelding, E Durante-Mangoni, N Fernández-Hidalgo, E Giannitsioti, M Hannan, T Lejko-Zupanc, J Miró, P Muñoz, D Murdoch, P Tattevin, C Tribouilloy, B Hoen, E Athan

(2015), Vol. 60, pp. 741-749, Clinical infectious diseases, Cary, N.C., C1-1

Effectiveness of a care bundle to reduce central line-associated bloodstream infections

D Entesari-Tatafi, N Orford, M Bailey, M Chonghaile, J Lamb-Jenkins, E Athan

(2015), Vol. 202, pp. 247-250, Medical journal of Australia, Strawberry Hills, N.S.W., C1-1

One-year outcome following biological or mechanical valve replacement for infective endocarditis

F Delahaye, V Chu, J Altclas, B Barsic, A Delahaye, T Freiberger, D Gordon, M Hannan, B Hoen, S Kanj, T Lejko-Zupanc, C Mestres, O Pachirat, P Pappas, C Lamas, C Selton-Suty, R Tan, P Tattevin, A Wang

(2015), Vol. 178, pp. 117-123, International journal of cardiology, Amsterdam, The Netherlands, C1-1

Mycobacterium ulcerans in the elderly: more severe disease and suboptimal outcomes

D O’Brien, N Friedman, R Cowan, J Pollard, A McDonald, P Callan, A Hughes, E Athan

(2015), Vol. 9, pp. 1-10, PLoS neglected tropical diseases, San Francisco, Calif., C1-1

Transmission of tuberculosis infection in a commercial office

M Bagherirad, P Trevan, M Globan, E Tay, N Stephens, E Athan

(2014), Vol. 200, pp. 177-179, Medical Journal of Australia, Strawberry Hills, NSW, C1

Clinical features and risk factors of oedematous mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area

D O'Brien, N Friedman, A McDonald, P Callan, A Hughes, E Athan

(2014), Vol. 8, pp. 1-6, PLoS neglected tropical diseases, San Francisco, Calif., C1-1

Community-onset Escherichia coli infection resistant to expanded- spectrum cephalosporins in low-prevalence countries

B Rogers, P Ingram, N Runnegar, M Pitman, J Freeman, E Athan, S Havers, H Sidjabat, M Jones, E Gunning, M De Almeida, K Styles, D Paterson

(2014), Vol. 58, pp. 2126-2134, Antimicrobial Agents and Chemotherapy, Washington, DC, C1-1

The characteristics and outcome of infective endocarditis involving implantable cardiac devices

E Athan

(2014), Vol. 16, pp. 1-5, Current infectious disease reports, Berlin, Germany, C1

Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014

C Chang, M Ananda-Rajah, A Belcastro, B McMullan, A Reid, K Dempsey, E Athan, A Cheng, M Slavin

(2014), Vol. 44, pp. 1389-1397, Internal medicine journal, Milton, Qld., C1

What do infectious diseases physicians do? a 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore

P Ingram, A Cheng, R Murray, C Blyth, T Walls, D Fisher, J Davis, E Athan

(2014), Vol. 20, pp. O737-O744, Clinical microbiology and infection, Amsterdam, The Netherlands, C1-1

Iatrogenic meningitis caused by Neisseria sicca/subflava after intrathecal contrast injection, Australia

D Entesari-Tatafi, M Bagherirad, D Quan, E Athan

(2014), Vol. 20, pp. 1023-1025, Emerging infectious diseases, Atlanta, Ga., C1-1

Compliance with surgical antibiotic prophylaxis at an Australian teaching hospital

N Friedman, K Styles, A Gray, J Low, E Athan

(2013), Vol. 41, pp. 71-74, American journal of infection control, Philadelphia, Pa., C1-1

The effectiveness of a single-stage versus traditional three-staged protocol of hospital disinfection at eradicating vancomycin-resistant enterococci from frequently touched surfaces

N Friedman, A Walton, S Boyd, C Tremonti, J Low, K Styles, O Harris, D Alfredson, E Athan

(2013), Vol. 41, pp. 227-231, American journal of infection control, Philadelphia, Pa., C1

Enterococcal endocarditis in the beginning of the 21st century: analysis from the international collaboration on endocarditis-prospective cohort study

C Chirouze, E Athan, F Alla, V Chu, R Corey, C Selton-Suty, M Erpelding, J Miro, L Olaison, B Hoen, International Collaboration on Endocarditis Study

(2013), Vol. 19, pp. 1140-1147, Clinical microbiology and infection, Chichester, England, C1-1

Staphylococcus aureus bacteraemia : evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis

A Incani, C Hair, P Purnell, D O'Brien, A Cheng, A Appelbe, E Athan

(2013), Vol. 32, pp. 1003-1008, European journal of clinical microbiology and infectious diseases, Heidelberg, Germany, C1

Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis : a retrospective cohort study

A Htin, D Friedman, A Hughes, D O'Brien, S Huffam, A Redden, E Athan

(2013), Vol. 43, pp. 700-705, Internal medicine journal, Richmond, Vic., C1-1

Risk factors for recurrent Mycobacterium ulcerans disease after exclusive surgical treatment in an Australian cohort

D O'Brien, A Walton, A Hughes, N Friedman, A McDonald, P Callan, R Rahdon, I Holten, E Athan

(2013), Vol. 198, pp. 436-439, Medical journal of Australia, Sydney, N. S. W., C1

Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort

N Friedman, E Athan, A Hughes, M Khajehnoori, A McDonald, P Callan, R Rahdon, D O'Brien

(2013), Vol. 7, pp. 1-5, PLoS neglected tropical diseases, San Francisco, Calif., C1

Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections

D O’Brien, M Robson, N Friedman, A Walton, A McDonald, P Callan, A Hughes, R Rahdon, E Athan

(2013), Vol. 13, pp. 1-10, BMC infectious diseases, London, England, C1-1

Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings

C Marshall, A Curtis, T Spelman, D O'Brien, J Greig, L Shanks, P du Cros, E Casas, M da Fonseca, E Athan, J Elliot

(2013), Vol. 8, pp. 1-8, PLoS one, San Francisco, Calif., C1

Forgotten but not gone - Scrofuloderma in a migrant student from India

M Bagherirad, E Athan, O Harris

(2013), Vol. 6, pp. 371-373, Australasian medical journal, Perth, WA, C1-1

A case of Kingella kingae endocarditis complicated by native mitral valve rupture

M Bagherirad, D Entesari-Tatafi, S Mirzaee, A Appelbe, C Yap, E Athan

(2013), Vol. 6, pp. 172-174, Australasian Medical Journal, Perth, WA, C1-1

HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort

S Chambers, D Murdoch, A Morris, D Holland, P Pappas, M Almela, N Fernández-Hidalgo, B Almirante, E Bouza, D Forno, A del Rio, M Hannan, J Harkness, Z Kanafani, T Lalani, S Lang, N Raymond, K Read, T Vinogradova, C Woods, D Wray, G Corey, V Chu, International Collaboration on Endocarditis Prospe, E Athan

(2013), Vol. 8, pp. 1-9, PLoS one, San Francisco, Calif., C1-1

Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke

B Barsic, S Dickerman, V Krajinovic, P Pappas, J Altclas, G Carosi, J Casabé, V Chu, F Delahaye, J Edathodu, C Fortes, L Olaison, A Pangercic, M Patel, I Rudez, S Tamin, J Vincelj, A Bayer, A Wang, K Anstrom, E Athan, A Bayer, C Cabell, G Corey, V Fowler Jr, B Hoen, A Karchmer, J Miro, D Murdoch, D Sexton

(2013), Vol. 56, pp. 209-217, Clinical infectious diseases, Oxford, Eng., C1-1

In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.

T Lalani, V Chu, L Park, E Cecchi, G Corey, E Durante-Mangoni, V Fowler, D Gordon, P Grossi, M Hannan, B Hoen, P Muñoz, H Rizk, S Kanj, C Selton-Suty, D Sexton, D Spelman, V Ravasio, M Tripodi, A Wang, International Collaboration on Endocarditis–Prospe, E Athan

(2013), Vol. 173, pp. 1495-1504, JAMA internal medicine, Chicago, IL, C1-1

The epidemiology of the first wave of H1N1 influenza pandemic in Australia : a population-based study

J Pasco, G Nicholson, S Brennan, K Bennett, A Dobbins, E Athan

(2012), Vol. 5, pp. 80-85, Open public health journal, Bussum, The Netherlands, C1

Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans : an observational cohort study

D O'Brien, A McDonald, P Callan, M Robson, N Friedman, A Hughes, I Holten, A Walton, E Athan

(2012), Vol. 6, pp. 1-7, PLoS neglected tropical diseases, San Francisco, Calif., C1-1

Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices

E Athan, V Chu, P Tattevin, C Selton-Suty, P Jones, C Naber, J Miro, S Ninot, N Fernandez-Hidalgo, E Durante-Mangoni, D Spelman, B Hoen, T Lejko-Zupanc, E Cecchi, F Thuny, M Hannan, P Pappas, M Henry, V Fowler, A Crowley, A Wang

(2012), Vol. 307, pp. 1727-1735, JAMA: Journal of the American Medical Association, Chicago, Ill., C1-1

Early diagnosis and treatment of necrotizing fasciitis can improve survival : an observational intensive care unit cohort study

K Bucca, R Spencer, N Orford, C Cattigan, E Athan, A McDonald

(2012), Vol. 83, pp. 365-370, ANZ journal of surgery, Richmond, Vic., C1-1

Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population

S Boyd, E Athan, N Friedman, A Hughes, A Walton, P Callan, A McDonald, D O'Brien

(2012), Vol. 196, pp. 341-344, Medical journal of Australia, Sydney, N.S.W., C1-1

Treatment costs of Mycobacterium ulcerans in the antibiotic era

J Pak, D O'Brien, T Quek, E Athan

(2012), Vol. 4, pp. 123-127, International health, Amsterdam, The Netherlands, C1-1

Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins

J Nienaber, B Sharma Kuinkel, M Clarke-Pearson, S Lamlertthon, L Park, T Rude, S Barriere, C Woods, V Chu, M Marín, S Bukovski, P Garcia, G Corey, T Korman, T Doco-Lecompte, D Murdoch, L Reller, V Fowler, International Collaboration on Endocarditis-Microb

(2011), Vol. 204, pp. 704-713, Journal of infectious diseases, Oxford, Eng., C1-1

Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings

E Athan, D O'Brien, R Legood

(2010), Vol. 24, pp. 1887-1895, AIDS, Philadelphia, Pa., C1-1

Treatment for bacteraemia due to Staphylococcus aureus

A Cheng, M Yong, E Athan, V Fowler

(2009), pp. 1-10, Cochrane Database of Systematic Reviews, Chichester, Eng., C1-1

Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study

V Chu, J Miro, B Hoen, C Cabell, P Pappas, P Jones, M Stryjewski, I Anguera, S Braun, P Muñoz, P Commerford, P Tornos, J Francis, M Oyonarte, C Selton-Suty, A Morris, G Habib, B Almirante, D Sexton, G Corey, V Fowler, International Collaboration on Endocarditis-Prospe, E Athan

(2009), Vol. 95, pp. 570-576, Heart, London, Eng., C1-1

Health care-associated native valve endocarditis: importance of non-nosocomial acquisition

N Benito, J Miró, E de Lazzari, C Cabell, A del Río, J Altclas, P Commerford, F Delahaye, S Dragulescu, H Giamarellou, G Habib, A Kamarulzaman, A Kumar, F Nacinovich, F Suter, C Tribouilloy, K Venugopal, A Moreno, V Fowler, ICE-PCS (International Collaboration on Endocardit

(2009), Vol. 150, pp. 586-594, Annals of internal medicine, Philadelphia, Pa., C1-1

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

D Murdoch, G Corey, B Hoen, J Miró, V Fowler, A Bayer, A Karchmer, L Olaison, P Pappas, P Moreillon, S Chambers, V Chu, V Falcó, D Holland, P Jones, J Klein, N Raymond, K Read, M Tripodi, R Utili, A Wang, C Woods, C Cabell, International Collaboration on Endocarditis-Prospe

(2009), Vol. 169, pp. 463-473, Archives of internal medicine, Chicago, IL., C1-1

Staphylococcal pyomyositis in a temperate region : epidemiology and modern management

A Block, C Marshall, A Ratcliffe, E Athan

(2008), Vol. 189, pp. 323-325, Medical journal of Australia, Sydney, N. S. W., C1-1

Preventing invasive fungal infection during hospital building works

C Chang, E Athan, C Morrissey, M Slavin

(2008), Vol. 38, pp. 538-541, Internal medicine journal, Hoboken, N. J., C1-1

Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report

D O'Brien, E Athan, A Hughes, P Johnson

(2008), Vol. 2, pp. 1-4, Journal of medical case reports, London, England, C1-1

Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works

C Chang, A Cheng, B Devitt, A Hughes, P Campbell, K Styles, J Low, E Athan

(2008), Vol. 69, pp. 33-38, Journal of hospital infection, Amsterdam, The Netherlands, C1-1

Genotypic diversity of coagulase-negative staphylococci causing endocarditis : a global perspective

C Petti, K Simmon, J Miro, B Hoen, F Marco, V Chu, E Athan, S Bukovski, E Bouza, S Bradley, V Fowler, E Giannitsioti, D Gordon, P Reinbott, T Korman, S Lang, C Garcia-de-la-Maria, A Raglio, A Morris, P Plesiat, S Ryan, T Doco-Lecompte, F Tripodi, R Utili, D Wray, J Federspiel, K Boisson, L Reller, D Murdoch, C Woods

(2008), Vol. 46, pp. 1780-1784, Journal of clinical microbiology, Washington, D. C., C1-1

Candida infective endocarditis

J Baddley, D Benjamin, M Patel, J Miró, E Athan, B Barsic, E Bouza, L Clara, T Elliott, Z Kanafani, J Klein, S Lerakis, D Levine, D Spelman, E Rubinstein, P Tornos, A Morris, P Pappas, V Fowler, V Chu, C Cabell

(2008), Vol. 27, pp. 519-529, European journal of clinical microbiology and infectious diseases, Heidelberg, Germany, C1-1

Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis

V Chu, C Woods, J Miro, B Hoen, C Cabell, P Pappas, J Federspiel, E Athan, M Stryjewski, F Nacinovich, F Marco, D Levine, T Elliot, C Fortes, P Tornos, D Gordon, R Utili, F Delahaye, G Corey, J Fowler

(2008), Vol. 46, pp. 232-242, Clinical infectious diseases, Cary, N. C., C1-1

Leptotrichia endocarditis: report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases.

L Caram, J Linefsky, K Read, D Murdoch, T Lalani, C Woods, L Reller, S Kanj, M Premru, S Ryan, M Al-Hegelan, P Donnio, C Orezzi, M Paiva, C Tribouilloy, R Watkin, O Harris, D Eisen, G Corey, C Cabell, C Petti, E Athan

(2008), Vol. 27, pp. 139-143, European jouranl of clinical microbiology and infectious diseases, Berlin, Germany, C1-1

Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.

E Durante-Mangoni, S Bradley, C Selton-Suty, M-F Tripodi, B Barsic, E Bouza, C Cabell, A Ramos, V Fowler, B Hoen, P Koneçny, A Moreno, D Murdoch, P Pappas, D Sexton, D Spelman, P Tattevin, J Miró, J van der Meer, R Utili, International Collaboration on Endocarditis Prospe

(2008), Vol. 168, pp. 2095-2103, Archives of internal medicine, Chicago, IL., C1-1

Risk factors for Mycobacterium ulcerans infection, southeastern Australia

T Quek, E Athan, M Henry, J Pasco, J Redden-Hoare, A Hughes, P Johnson

(2007), Vol. 13, pp. 1661-1666, Emerging infectious diseases, Atlanta, Ga., C1-1

Mycobacterium ulcerans infection : factors influencing diagnostic delay

T Quek, M Henry, J Pasco, D O'Brien, P Johnson, A Hughes, A Cheng, J Redden-Hoare, E Athan

(2007), Vol. 187, pp. 561-563, Medical journal of Australia, Sydney, N.S.W., C1-1

Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia

P Johnson, J Hayman, T Quek, J Fyfe, G Jenkin, J Buntine, E Athan, M Birrell, J Graham, C Lavender, Mycobacterium ulcerans Study Team

(2007), Vol. 186, pp. 64-68, The Medical journal of Australia, Strawberry Hills, N.S.W., C1-1

Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza

A Swaminathan, R Martin, S Gamon, C Aboltins, E Athan, G Braitberg, M Catton, L Cooley, D Dwyer, D Edmonds, D Eisen, K Hosking, A Hughes, P Johnson, A Maclean, M O'Reilly, S Peters, R Stuart, R Moran, M Grayson

(2007), Vol. 13, pp. 1541-1547, Emerging infectious diseases, Atlanta, Ga., C1-1

Pacemaker infections: a 10-year experience

A Catanchin, C Murdock, E Athan

(2007), Vol. 16, pp. 434-439, Heart, Lung and Circulation, Chatswood, N.S.W., C1-1

Non-HACEK gram-negative bacillus endocarditis

S Morpeth, D Murdoch, C Cabell, A Karchmer, P Pappas, D Levine, F Nacinovich, P Tattevin, N Fernández-Hidalgo, S Dickerman, E Bouza, A del Río, T Lejko-Zupanc, A de Oliveira Ramos, D Iarussi, J Klein, C Chirouze, R Bedimo, G Corey, V Fowler, E Athan

(2007), Vol. 147, pp. 829-835, Annals of internal medicine, Philadelphia, Pa., C1-1

Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit

K Field, C McFarlane, A Cheng, A Hughes, E Jacobs, K Styles, J Low, P Stow, P Campbell, E Athan

(2007), Vol. 28, pp. 610-613, Infection Control and Hospital Epidemiology, New York, N.Y., C1-1

Contemporary clinical profile and outcome of prosthetic valve endocarditis

A Wang, E Athan, P Pappas, V Fowler, L Olaison, C Paré, B Almirante, P Muñoz, M Rizzi, C Naber, M Logar, P Tattevin, D Iarussi, C Selton-Suty, S Jones, J Casabé, A Morris, G Corey, C Cabell, International Collaboration on Endocarditis-Prospe

(2007), Vol. 297, pp. 1354-1361, JAMA: Journal of the American Medical Association, Chicago, Ill., C1-1

Q fever outbreak at a cosmetics supply factory

A Wade, A Cheng, E Athan, J Molloy, O Harris, J Stenos, A Hughes

(2006), Vol. 42, pp. e50-e52, Clinical infectious diseases, United States, C1-1

Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam

S Jones, V Nguyen, T Nguyen, E Athan

(2006), Vol. 11, pp. 1725-1730, Tropical medicine & international health, Chichester, Eng., C1-1

Acute rheumatic fever: an unusual cause of fever in a returned traveler

A Catanchin, D O'Brien, E Athan

(2005), Vol. 12, pp. 353-355, Journal of travel medicine, Oxford, Eng., C1-1

Staphylococcus aureus endocarditis: a consequence of medical progress

V Fowler, J Miro, B Hoen, C Cabell, E Abrutyn, E Rubinstein, G Corey, D Spelman, S Bradley, B Barsic, P Pappas, K Anstrom, D Wray, C Fortes, I Anguera, E Athan, P Jones, J van der Meer, T Elliott, D Levine, A Bayer

(2005), Vol. 293, pp. 3012-3021, Journal of the American Medical Association, Chocago, Ill., C1-1

Peritonitis due to Curvularia inaequalis in an elderly patient undergoing peritoneal dialysis and a review of six cases of peritonitis associated with other Curvularia spp

J Pimentel, K Mahadevan, A Woodgyer, L Sigler, C Gibas, O Harris, M Lupino, E Athan

(2005), Vol. 43, pp. 4288-4292, Journal of clinical microbiology, Washington, D.C., C1-1

Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.

D Lye, A Hughes, D O'Brien, E Athan

(2005), Vol. 24, pp. 753-755, European Journal of Clinical Microbiology and Infectious Diseases, Germany, C1-1

Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward

J Pimentel, J Low, K Styles, O Harris, A Hughes, E Athan

(2005), Vol. 59, pp. 249-253, Journal of hospital infection, Amsterdam, The Netherlands, C1-1

The tip of the iceberg: opportunistic screening for Chlamydia trachomatis in asymptomatic patients attending a young people's health clinic reveals a high prevalence - a pilot study

S Jones, S Barker, E Athan, S Graves

(2004), Vol. 1, pp. 115-119, Sexual health, Clayton, Vic., C1-1

Prevention of recurrent fetal death in utero due to group B streptococcal chorioamnionitis

S Jones, E Athan, J Viggers

(2004), Vol. 44, pp. 356-357, ANZJOG (Australian and New Zealand Journal of Obstetrics and Gynaecology), Richmond, Vic., C1-1

AIDS and heart disease: is cardiac surgery justified?

M Agaskar, N Ghorpade, E Athan, M Mohajeri

(2003), Vol. 12, pp. 193-195, Heart, lung and circulation, Amsterdam, The Netherlands, C1-1

Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults

M Grayson, M McDonald, K Gibson, E Athan, W Munckhof, P Paull, F Chambers

(2002), Vol. 34, pp. 1440-1448, Clinical infectious diseases, Oxford, Eng., C1-1

The changing profile of bacterial endocarditis as seen at an Australian provincial centre

A Cheng, E Athan, A Appelbe, M McDonald

(2002), Vol. 11, pp. 26-31, Heart, lung and circulation, Amsterdam, The Netherlands, C1-1

Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa

E Athan, D Dürrheim, K Barnes, N Mngomezulu, A Mabuza, J Govere

(2001), Vol. 91, pp. 592-594, South African Medical Journal (SAMJ), Claremont, South Africa, C1-1

Anaerobic meningitis due to Peptostreptococcus species: case report and review

T Korman, E Athan, D Spelman

(1997), Vol. 25, pp. 1462-1464, Clinical infectious diseases, Oxford, Eng., C1-1